Nelfinavir mesylate

Nelfinavir Mesylate is an antiretroviral medication used in the treatment of HIV infections. It belongs to the class of drugs known as protease inhibitors, which work by inhibiting the action of the HIV protease enzyme, thereby preventing the virus from multiplying in the body.

Pharmacology

Nelfinavir Mesylate is a type of protease inhibitor that works by blocking the action of an enzyme called HIV protease. This enzyme is necessary for the HIV virus to replicate and spread in the body. By inhibiting this enzyme, Nelfinavir Mesylate prevents the virus from multiplying, thereby reducing the amount of virus in the body.

Clinical Use

Nelfinavir Mesylate is used in combination with other antiretroviral drugs for the treatment of HIV infection. It is not a cure for HIV or AIDS, but it can help to control the infection and delay the progression of the disease.

Side Effects

Like all medications, Nelfinavir Mesylate can cause side effects. Common side effects include nausea, diarrhea, and rash. More serious side effects can include liver problems and changes in body fat distribution.

Drug Interactions

Nelfinavir Mesylate can interact with a number of other medications, including certain other antiretroviral drugs, antibiotics, and antifungal medications. It is important for patients to inform their healthcare provider of all medications they are taking to avoid potential drug interactions.

Dosage

The dosage of Nelfinavir Mesylate will vary depending on the patient's age, weight, and overall health status, as well as the severity of the HIV infection. It is typically taken twice daily with meals.

See Also

• Antiretroviral therapy
• Protease inhibitors
• HIV/AIDS

This HIV/AIDS related article is a stub. You can help WikiMD by expanding it.